Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 11.3414.7129.3720.808.85

What is the latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS is 11.34 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202411.34
Mar202314.71
Mar202229.37
Mar202120.80
Mar20208.85

How is EV/Core EBITDA of FREDUN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 11.34
-22.91
Mar2023 14.71
-49.91
Mar2022 29.37
41.20
Mar2021 20.8
135.03
Mar2020 8.85 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹589.4 Cr 18.8% 37.4% 41.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,187.0 Cr 0.6% -2.4% -7% Stock Analytics
DIVIS LABORATORIES ₹163,282.0 Cr -0.3% -7.6% 23% Stock Analytics
CIPLA ₹128,619.0 Cr 1.8% 8.1% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,712.0 Cr 0.9% 3.7% 8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,577.0 Cr 1% 2.4% -9.6% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

18.8%

37.4%

41.1%

SENSEX

0.9%

-1.1%

0.6%


You may also like the below Video Courses